Cargando…
Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
Non-alcoholic steatohepatitis (NASH) is characterized by inflammation and fibrosis, in addition to steatosis, of the liver, but no therapeutic agents have yet been established. The mast cell protease chymase can generate angiotensin II, matrix metalloproteinase-9 and transforming growth factor-β, al...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826365/ https://www.ncbi.nlm.nih.gov/pubmed/29515450 http://dx.doi.org/10.3389/fphar.2018.00144 |